On this page
Yes. Gallstones and an inflamed gallbladder are recognized risks on semaglutide and tirzepatide, and both drug labels list them. But much of that risk may come from something much older than any GLP-1. Losing weight fast is one of the best-established causes of gallstones, and these drugs are very good at making you lose weight fast.
So GLP-1s do affect the gallbladder. The useful question is how much of that comes from the medication and how much from the weight coming off.
Fast weight loss has always caused gallstones
This link goes back decades before GLP-1s. Crash diets, very-low-calorie diets, and bariatric surgery all raise gallstone rates, for the same mechanical reasons.
Two things happen when weight comes off quickly. First, as your body burns stored fat, your liver puts more cholesterol into bile, the fluid that helps you digest fat. Bile with too much cholesterol in it forms crystals. Second, you’re eating less, and eating less fat. Your gallbladder squeezes when fat reaches your small intestine, so with less fat it squeezes less often. Bile that should get flushed out just sits there. Bile overloaded with cholesterol, plus a sluggish gallbladder, is exactly how cholesterol stones form.
GLP-1s push hard on both. In STEP 1, people on brand-name semaglutide (Wegovy) 2.4 mg lost 14.9% of their body weight on average at 68 weeks. In SURMOUNT-1, people on the top dose of brand-name tirzepatide (Zepbound) lost 20.9%. That’s the size and speed of weight loss that has always carried gallstone risk. Now it comes from a weekly injection instead of a starvation diet.
What the labels actually say
The semaglutide and tirzepatide labels both list cholelithiasis (gallstones) and cholecystitis (an inflamed gallbladder) as side effects. They also flag acute gallbladder disease as something to watch for. In the trials, these events were uncommon, but they happened more often than on placebo. Pooled analyses of the trial data have linked GLP-1 drugs to more gallbladder and bile duct disease overall. The signal was strongest at the higher doses used for weight loss.
For the fuller side-effect picture, including nausea, reflux, and constipation, see our GLP-1 side effects guide. This page sticks to the gallbladder.
Is it the drug or the weight loss? We don’t fully know.
Here’s the honest part. Higher doses cause more weight loss, and more weight loss causes more gallstones. So you’d expect more gallbladder problems at higher doses even if the drug never touched the gallbladder directly. Pooled trial and real-world data can’t cleanly separate the two. There may also be a direct effect, since GLP-1 signaling may slow gallbladder emptying on its own. But “may” is as far as the evidence goes. How much of the risk comes from the drug and how much from the weight loss is still truly unresolved.
That uncertainty doesn’t change a few things. The risk is real, it can be managed, and the symptoms to watch for are the same either way.
Symptoms that need same-day care
Most gallstones never cause trouble, but the ones that do make themselves known, and some are urgent.
Steady, severe pain in the upper right abdomen or just under the breastbone, often after a fatty meal, needs in-person care right away if it lasts more than an hour or spreads to your right shoulder or back. Go to urgent care or the emergency room instead of waiting on a message.
With any of these, go now. Don’t wait and see:
- Fever or chills along with the pain
- Yellow skin or eyes (jaundice)
- Dark pee, or pale, clay-colored poop
- Throwing up that won’t stop
- Bad pain high in the belly that goes straight through to your back. That’s the classic sign of pancreatitis (an inflamed pancreas), which the labels also warn about.
Pain with fever, or pain with yellow skin or eyes, can mean an infected or blocked bile duct. That’s a medical emergency.
Severe pain under your right ribs that lasts more than an hour means a trip to the emergency room. Don’t send us a message. It isn’t certain to be your gallbladder. But gallstone pain, an inflamed gallbladder, and pancreatitis can’t be told apart over text. Two of the three need imaging and blood work within a few hours. If you also have fever, vomiting you can’t stop, or yellowing of your eyes or skin, it’s even more urgent.
For anything milder, like an ache after fatty meals or discomfort that comes and goes over several days, message us. It’s worth reviewing against your dose and your history, and it isn’t an ER problem.
If you’ve had gallstones, or your gallbladder is already out
Neither one rules out treatment. Both change the advice, and how quickly a clinician would stop and reassess.
You’ve had gallstones and still have your gallbladder. You can still be treated. Your chance of a gallbladder event during treatment may be higher, and the reason isn’t that the old stones make the drug more harmful. Three things may add up. GLP-1s may slow gallbladder emptying, so bile can sit. Fast weight loss makes stones on its own. And whatever made you form stones in the first place, such as obesity, diabetes, high triglycerides, or estrogen exposure, hasn’t gone away. The person at highest practical risk has an intact gallbladder, a history of stones, and fast early weight loss.
Your gallbladder has been removed. That takes cholecystitis off the table, which is the largest single piece of the risk. But it doesn’t clear everything. If you formed stones once, you may still form them in the bile duct. So new pain after meals, jaundice, or certain liver test results still get a proper workup. They don’t get brushed off because the gallbladder is gone. Pancreatitis is a separate concern either way.
What matters most for prescribing is whether the gallbladder or bile duct problem is settled, more than the history itself. These are reasons to sort things out before you start:
- Recent gallbladder attacks
- A recent inflamed gallbladder or a stone stuck in the bile duct
- Past pancreatitis caused by gallstones
- Abnormal liver tests with no known cause
Stones that were found by chance, long ago, and never caused symptoms matter much less.
If you’re cleared to start, the practical change is pace. Clinicians usually avoid pushing the dose up (titrating) through rapid weight loss or stomach trouble. And new belly pain shouldn’t be written off as “GLP-1 nausea.” It usually needs an in-person exam and blood tests, such as liver enzymes, bilirubin, and lipase (a pancreas test), and sometimes imaging.
What to do with this
Don’t let this talk you out of treatment, but do learn the warning signs. If you’ve had gallstones before, or had your gallbladder removed, tell your clinician before you start. It’s a conversation, not an automatic no. And if pain in the upper right abdomen shows up, act on it early, because gallbladder disease is treatable when it’s caught fast.
If you’re wondering whether semaglutide or tirzepatide fits your history, start with the intake quiz. A clinician reviews every case within 24 hours, including your gallbladder history.
